Skip to content

LBRX LBRX Current ratio

Current ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
1.4×+0.1×
Alkermes logo
AlkermesALKS
2.3×-1.1×
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
22.9×
Alto Neuroscience logo
Alto NeuroscienceANRO
20.5×-2.0×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
4.9×+1.9×
Opko Health logo
Opko HealthOPK
3.6×+1.1×

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$874.06M+159%
Enterprise value$556.86M

Returns & leverage

See full
Return on equity-27.9%
Debt / equity

Where this comes from

Calculated from LBRX’s reported figures.

Based on the most recent quarter.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LBRX's current ratio?
LBRX (LBRX) reported current ratio of 35.7× in Q1 2026.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.